Cargando…
504P SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer
Autores principales: | Pinato, D.J., Aguilar-Company, J., Bertuzzi, A., Hanbury, G.H., Bower, M.D., Salazar, R., Lambertini, M., Pedrazzoli, P., Lee, A.J.X., Sinclair, A., Townsend, S., Plaja Salarich, A., Sita-Lumsden, A.R., Mukherjee, U., Diamantis, N., Sharkey, R., Gaidano, G., Gennari, A., Tabernero, J., Cortellini, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472535/ http://dx.doi.org/10.1016/j.annonc.2022.07.632 |
Ejemplares similares
-
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
por: Cortellini, Alessio, et al.
Publicado: (2023) -
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
por: Pinato, David J, et al.
Publicado: (2022) -
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
por: Cortellini, Alessio, et al.
Publicado: (2022) -
1565MO Time-dependent improvement in the clinical outcomes from COVID-19 in cancer patients: An updated analysis of the OnCovid registry
por: Pinato, D.J., et al.
Publicado: (2021) -
First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
por: Carrazco-Montalvo, A., et al.
Publicado: (2022)